Amplicon details

Amplicon:

215 bp
1     ctcaccttgc tcctgccgag aaagtatcca tcatggctga tgcaatgcgg
51    cggctgcata cgcttgatcc ggctacctgc ccattcgacc accaagcgaa
101   acatcgcatc gagcgagcac gtactcggat ggaagccggt cttgtcgatc
151   aggatgatct ggacgaagag catcaggggc tcgcgccagc cgaactgttc
201   gccaggctca aggcg 

An identical amplicon is found in the following matches:

Record ID Database Record description Record length Taxon Method Amplicon size Match details
LZ186249.1 emblrelpat JP 2017141261-A/12: THERAPEUTIC COM... 8003 bp synthetic construct QL-ELE-00-002 215 bp View
LZ186250.1 emblrelpat JP 2017141261-A/13: THERAPEUTIC COM... 7916 bp synthetic construct QL-ELE-00-002 215 bp View
LZ186251.1 emblrelpat JP 2017141261-A/14: THERAPEUTIC COM... 7662 bp synthetic construct QL-ELE-00-002 215 bp View
LZ186252.1 emblrelpat JP 2017141261-A/15: THERAPEUTIC COM... 7931 bp synthetic construct QL-ELE-00-002 215 bp View
LZ186253.1 emblrelpat JP 2017141261-A/16: THERAPEUTIC COM... 7931 bp synthetic construct QL-ELE-00-002 215 bp View
MO961677.1 emblrelpat Sequence 18 from patent US 10597429. 5305 bp unidentified QL-ELE-00-002 215 bp View
LZ186255.1 emblrelpat JP 2017141261-A/18: THERAPEUTIC COM... 8084 bp synthetic construct QL-ELE-00-002 215 bp View
LZ186256.1 emblrelpat JP 2017141261-A/19: THERAPEUTIC COM... 8122 bp synthetic construct QL-ELE-00-002 215 bp View
LZ186258.1 emblrelpat JP 2017141261-A/21: THERAPEUTIC COM... 8035 bp synthetic construct QL-ELE-00-002 215 bp View
LZ207974.1 emblrelpat WO 2017131097-A/1: Adamantane deriv... 6631 bp synthetic construct QL-ELE-00-002 215 bp View
LZ217145.1 emblrelpat JP 2017520256-A/1: T7 EXPRESSION SY... 5990 bp synthetic construct QL-ELE-00-002 215 bp View
LZ217186.1 emblrelpat JP 2017520256-A/42: T7 EXPRESSION S... 9023 bp synthetic construct QL-ELE-00-002 215 bp View
LZ218946.1 emblrelpat JP 2017158550-A/17: Therapeutic use... 6165 bp synthetic construct QL-ELE-00-002 215 bp View
MO962682.1 emblrelpat Sequence 371 from patent US 10597648. 5933 bp unidentified QL-ELE-00-002 215 bp View
MO962689.1 emblrelpat Sequence 378 from patent US 10597648. 8114 bp unidentified QL-ELE-00-002 215 bp View
LZ230690.1 emblrelpat JP 2017192342-A/4: Method of produc... 795 bp synthetic construct QL-ELE-00-002 215 bp View
MO962697.1 emblrelpat Sequence 386 from patent US 10597648. 6854 bp unidentified QL-ELE-00-002 215 bp View
MO962732.1 emblrelpat Sequence 451 from patent US 10597648. 6547 bp unidentified QL-ELE-00-002 215 bp View
MO964035.1 emblrelpat Sequence 1805 from patent US 10597648. 8750 bp unidentified QL-ELE-00-002 215 bp View
MO964042.1 emblrelpat Sequence 1812 from patent US 10597648. 8729 bp unidentified QL-ELE-00-002 215 bp View


Related publications:

Petrillo, M., et al. “JRC GMO-Amplicons: A Collection of Nucleic Acid Sequences Related to Genetically Modified Organisms.” Database (Oxford), vol. 2015 bav101, 30 Sep. 2015, doi:10.1093/database/bav101. 

Angers-Loustau, A., et al. “Using the EURL GMFF Online Bioinformatics Resources: A how-to Guide for Practical JRC GMO-Matrix and JRC GMO-Amplicons Case Uses.” European Commission, Ispra, JRC101853, 2016.